A new study found that a combination of hormone therapy and the GLP-1 medication tirzepatide (Zepbound) led to 35% more ...
Her research work is conducted within the NIHR Cambridge Biomedical Research Centre (BRC) Mental Health and Neurodegeneration ...
Experts explain the latest research.
A UK Biobank suggests hormone replacement therapy may offer only limited protection for mental health and cognition in ...
The FDA has approved drug label changes to six menopausal hormone replacement therapies (HRT), according to a recent news release. This was done to clarify risks for taking these drugs, specifically ...
Mediafeed on MSN
Progestin vs. progesterone for menopause: Which is best for me?
This article was reviewed by Lynn Marie Morski, MD, JD. Key Takeaways: Progesterone is a natural reproductive hormone that ...
The FDA has lifted longstanding and the most severe warnings off of hormone replacement therapies for menopausal women.
Women should not suffer through menopause with hot flashes, night sweats and poor sleep. That's the message from FDA Commissioner Dr. Marty Makary. The agency announced it will remove "black box" ...
The FDA no longer requires a safety warning on hormone-replacement therapies, at a time when more attention is being paid to perimenopause and menopause Menopause care has long been a casualty of bad ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results